News & Articles
Selected Filters:
Establishing Phantoms to Improve MRI Signal and Quality
SelectScience® spoke to Dr Michael Boss, NIST, about his work to improve brain imaging
Human Exposure to Organic Flame Retardants: Knowns and Unknowns
Stuart Harrad, University of Birmingham, UK, presents ‘The Organic Flame Retardant Story’
PerkinElmer Opens New Diagnostics Facility in Chennai
Laboratory expands access to innovative solutions for safer pregnancies and healthier babies in India
WaferGen Announces Key Findings from Collaborators Utilizing Company’s ICELL8™ Single-Cell System at AGBT 2016 General Meeting
Results from Genentech, Karolinska Institutet, National Jewish Health, and MD Anderson Cancer Center Highlight ICELL8™ Single-Cell System Performance
UTA Electrical Engineers Develop Device to Diagnose Cancer Rapidly at the Cellular Level, Improve Early Detection
The key to fighting cancer in many cases is early detection, and earlier detection at the cellular level could mean survival for many cancer patients
News From the Forefront of Cancer Diagnostics
SelectScience publishes breaking news from the cancer diagnostics industry
Crown Bioscience to Commercialize University of York's Prostate Cancer Models for Drug Development
Crown Bioscience to Commercialize University of York's Prostate Cancer Models for Drug Development
One-Hour Diagnosis of Heart Attack Possible with Troponin T Test from Roche
Novel strategy shortens time to heart attack diagnosis drastically, enabling faster start of treatment of patients and better use of healthcare resources
Mayo Clinic's Dr Joseph Mikhael Discusses Evolving Multiple Myeloma Clones
Dr Joseph Mikhael addresses the delegation during the 7th International Binding Site Symposium
Illumina Forms New Company to Enable Early Cancer Detection via Blood-Based Screening
Illumina Forms New Company to Enable Early Cancer Detection via Blood-Based Screening
Dako, an Agilent Technologies Company, Announces Expanded FDA Approval of Complementary Diagnostic Test to Include Melanoma
Dako, an Agilent Technologies Company, Announces Expanded FDA Approval of Complementary Diagnostic Test to Include Melanoma
Protagen Supports Novel Route to Serum Based Prostate Cancer Diagnostics
Protagen Supports Novel Route to Serum Based Prostate Cancer Diagnostics
The Latest Cutting Edge Cancer Methods Available for Download
The SelectScience article library contains downloads on the very latest technologies being used in cancer research and diagnostics
Exclusive Interviews with Scientists’ Choice Awards® Winner and Nominees
Hear from the winner of the Best New Drug Discovery Product of 2015, Thermo Fisher Scientific
Envigo Rat Models Proven to be Susceptible to Intra-Vaginal HSV-2 Infection and Protectable by Attenuated HSV-1 Against Symptomatic HSV-2
Scientific findings establish the effectiveness of Envigo’s new approach to investigate the protective effects of vaccine candidates and anti-viral microbodies and to study asymptomatic primary genital HSV-2 infection
Cancer Diagnostics: A 2016 Update
An overview of new developments in the field of cancer diagnostics
Rockland Immunochemicals, Inc. Introduces Melanoma Cell Lines in Collaboration with The Wistar Institute
Rockland Immunochemicals, Inc. Introduces Melanoma Cell Lines in Collaboration with The Wistar Institute
Thermo Fisher Scientific Wins the Scientists’ Choice Award® for Best New Drug Discovery Product of 2015
Discover the winning product, voted for by scientists worldwide